ArticlePDF Available

Holoprosencephaly: A Rare Finding in Mosaic Trisomy 9 Syndrome

Authors:

Abstract

Mosaic trisomy 9 syndrome is a rare chromosomal abnormality and is well defined with dysmorphologic features such as upslanting and short palpebral fissures; deeply set eyes; micrognathia; and cardiovascular, genital, and brain abnormalities. Holoprosencephaly, a developmental brain abnormality, is a rarely seen in patients with mosaic trisomy 9 syndrome. Here we present a case of a patient with mosaic trisomy 9 syndrome with alobar type holoprosencephaly who died in the first hour of the natal period. As per the literature, this is the third case of mosaic trisomy 9 with holoprosencephaly to be reported. Therefore, we believe that holoprosencephaly might take part among the classic dysmorphic features of mosaic trisomy 9 syndrome.
CASE REPORT
54
1Department of Medical
Genetics, Gazi University
Faculty of Medicine, Ankara,
Turkey
2Department of Perinatology,
Gazi University Faculty of
Medicine, Ankara, Turkey
Submitted
05.08.2017
Accepted
25.01.2018
Correspondence
Serdar Mermer, Department
of Medical Genetics,
Gazi University Faculty of
Medicine, Ankara, Turkey
Phone: +90312 202 44 44
e.mail:
doctorserdar@gmail.com,
doctorserdar@yahoo.com
©Copyright 2018
by Erciyes University Faculty of
Medicine - Available online at
www.erciyesmedj.com
Holoprosencephaly: A Rare Finding in Mosaic
Trisomy 9 Syndrome
Serdar Mermer1, Murat Özek2, Ferda Perçin1, Meral Karaoğuz1, Merih Bayram2
ABSTRACT Mosaic trisomy 9 syndrome is a rare chromosomal abnormality and is well defined with dysmorphologic features such as
upslanting and short palpebral fissures; deeply set eyes; micrognathia; and cardiovascular, genital, and brain abnormalities.
Holoprosencephaly, a developmental brain abnormality, is a rarely seen in patients with mosaic trisomy 9 syndrome. Here we
present a case of a patient with mosaic trisomy 9 syndrome with alobar type holoprosencephaly who died in the first hour of
the natal period. As per the literature, this is the third case of mosaic trisomy 9 with holoprosencephaly to be reported. There-
fore, we believe that holoprosencephaly might take part among the classic dysmorphic features of mosaic trisomy 9 syndrome.
Keywords: Holoprosencephaly, mosaic trisomy 9, PTCH1
Erciyes Med J 2018; 40(1): 54-6 • DOI: 10.5152/etd.2018.17094
INTRODUCTION
Holoprosencephaly (HPE), one of the most common developmental anomalies of the brain, is a clinical presen-
tation resulting from the failure of the prosencephalon to develop into two hemispheres in the early stages of
embryogenesis (1). Even though HPE, which displays genetic heterogeneity, can occur alongside numerical and
structural chromosomal abnormalities, it is also associated with monogenic and oligogenic syndromes as well as
environmental factors. While chromosomal abnormalities are identified in 24%–45% of HPE cases, trisomy 13 is
most frequently reported (2, 3). The case of holoprosencephaly presented here is accompanied by mosaic trisomy
9 syndrome, and based on our research, this is the third such reported case in the literature (4, 5).
CASE REPORT
Fetal ultrasound and echocardiography performed on the fetus of a 36-year-old woman during her first pregnancy
within the 21st week of gestation revealed intrauterine growth retardation (IUGR), absent nasal bone, bilateral
microphthalmia, holoprosencephaly, diaphragmatic hernia, atrioventricular septal defect, tricuspid atresia, and
pulmonary hypoplasia. The family, who were recommended amniocentesis, refused the invasive procedure, and
the baby was born through spontaneous vaginal delivery in the 39th week of pregnancy, with an Apgar score
of 3/6. The infant developed cardiopulmonary arrest and was unresponsive to resuscitation, resulting in death.
The deceased female infant was referred to our medical genetics department for genetic examination. A post-
mortem dysmorphological examination of the infant resulted in the discovery of brachycephaly, narrow forehead,
hypotelorism, deeply set eyes, microphthalmia, flattened nasal bridge with one nostril, posteriorly rotated ears,
camptodactyly, and bilateral single palmar crease (Figures 1 and 2). post-mortem brain tomography of the infant
revealed alobar holoprosencephaly (Figure 3), and the cytogenetic analysis of the fibroblast cell culture from two
separate flasks of skin biopsy from the antecubital region of the infant revealed mosaic trisomy 9 syndrome (mos
47,XX,+9[6]/46,XX[54]).
In this present case, the study of possible mutations, mainly in genes such as sonic hedgehog (SHH) and PTCH1,
related with the etiology of HPE, could not be performed because the limited amount of post-mortem skin material
was used up in the long-term tissue culture to obtain the metaphase plaques.
DISCUSSION
Mosaic trisomy 9 syndrome is a rare chromosomal anomaly wherein the affected cases usually exhibit IUGR,
micrognathia, low-set ears, rocker-bottom feet, and congenital heart anomalies. In certain rarer cases, various
anomalies of the central nervous system, including hydrocephaly, lissencephaly, and agenesis of the corpus cal-
losum as well as microcephaly, microphthalmia, cleft lip and palate, diaphragmatic hernia, simian crease, and
Cite this article as:
Mermer S, Özek M,
Perçin F, Karaoğuz
M, Bayram M.
Holoprosencephaly: A
rare nding in mosaic
trisomy 9 syndrome.
Erciyes Med J 2018;
40(1): 54-6.
genitourinary anomalies, can also be seen (6). Holoprosencephaly
is a heterogeneous clinical situation linked to various genetic com-
ponents where chromosomal aberrations also play a role. Non-
syndromic holoprosencephaly can be related with heterozygous
mutation of the SHH, ZIC2, SIX3, and TIGF1 genes; however,
in rare cases, a possible link to the patched1 (PTCH1) gene lo-
calized to the ninth chromosome and that suppresses the SHH
pathway has also been reported (7). SHH, a morphogen that plays
a role in the reproduction, position, and organization of cells within
developing tissue during the embryonic stage, is linked to Type
3 HPE (MIM: 142945), and the PTCH1 gene that encodes the
receptors for SHH is linked to Type 7 HPE (MIM: 610828) (8, 9).
In addition to suppressing the SHH pathway, a further relation is
also suggested between HPE and a mutation or gene duplication
resulting in an increase in the functions of the PTCH1 gene (10).
In the present case, the study of possible mutations, particularly in
genes such as SHH and PTCH1 related with the etiology of HPE,
could not be performed, as the limited amount of post-mortem
skin material was used up in the long-term tissue culture to obtain
the metaphase plaques.
Two other cases with similar clinical findings to ours (IUGR, flat-
tened nasal bridge, low-set ears, ventricular septal defect), where
HPE and mosaic trisomy 9 syndrome are found together, exist
in the literature. In contrast to our case, HPE is of the lobar type
in these cases (4, 5). In addition, no HPE was discovered in the
brain tomography of the Kaminker et al. (11) case diagnosed with
mosaic trisomy 9 syndrome. Nevertheless, taking into account the
imaging technology available at the time, it is possible that either
HPE was not discovered or the case may have been a microform
of HPE. Moreover, holoprosencephaly detected in our case may
have developed as a result of a dose increase in the PTCH1 gene
located on the ninth chromosome. Structural brain abnormalities
such as lissencephaly, hydrocephaly, and corpus callosum agenesis
have been reported in a comprehensive study of mosaic trisomy
9 syndrome cases. However, no holoprosencephaly anomaly was
detected in any of the 25 patients included in the article (12).
CONCLUSION
The fact that all three independent mosaic trisomy 9 syndrome
cases were accompanied by HPE supports the notion that HPE
may be a symptom of this aneuploidy as well as the suggestion by
other researchers that gain-of-function mutations of the PTCH1
gene may also cause HPE. However, further research is needed
to explain why this symptom is not present in all trisomy 9 cases.
Informed Consent: Written informed consent was obtained from patients
who participated in this study.
Peer-review: Externally peer-reviewed.
Author Contributions: Conceived and designed the experiments or case:
SM, MYK, FP. Performed the experiments or case: SM, MYK, MB, MO.
Analyzed the data: SM, MYK. Wrote the paper: SM, MYK.
All authors have read and approved the final manuscript.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study has received no
financial support.
Figure 1. Hypotelorism, flat nasal bridge, and microphthalmia
Figure 2. Single nostril
Figure 3. Alobar holoposencephaly in post-mortem cranial CT
55
Mermer et al. Holoprosencephaly with Mosaic Trisomy 9 SyndromeErciyes Med J 2018; 40(1): 54-6
REFERENCES
1. Lacbawan F, Solomon BD, Roessler E, El-Jaick K, Domené S, Vélez
JI, et al. Clinical spectrum of SIX3-associated mutations in holopros-
encephaly: correlation between genotype, phenotype and function. J
Med Genet 2009; 46(6): 389-98. [CrossRef]
2. Croen LA, Shaw GM, Lammer EJ. Holoprosencephaly: epidemio-
logic and clinical characteristics of a California population. Am J Med
Genet 1996; 64(3): 465-72. [CrossRef]
3. Olsen CL, Hughes JP, Youngblood LG, Sharpe-Stimac M. Epidemiol-
ogy of holoprosencephaly and phenotypic characteristics of affected
children: New York State, 1984-1989. Am J Med Genet 1997; 73(2):
217-26. [CrossRef]
4. Gerard-Blanluet M, Danan C, Sinico M, Lelong F, Borghi E, Dassieu
G, et al. Mosaic trisomy 9 and lobar holoprosencephaly. Am J Med
Genet 2002;111(3): 295-300. [CrossRef]
5. Yang Z. Mosaic Trisomy 9 in a Male Fetus with Severe Facial Ab-
normality and Genital Hypoplasia. Int J Hum Genet 2013; 13(2):
75-8. [CrossRef]
6. Jones KL, Jones MC, Del Campo M. Trisomy 9 Mosaic Syndrome.
Smith’s Recognizable Patterns of Human Malformation. 7th edition.
USA: Elsevier Health Sciences; 2013.p.28-9.
7. Mouden C, Dubourg C, Carré W, Rose S, Quélin C, Akloul L, et al.
Complex mode of inheritance in holoprosencephaly revealed by whole
exome sequencing. Clin Genet 2016; 89(6): 659-68. [CrossRef]
8. Roesslerl E, Belloniz E, Gaudenzl K, Iay P, Berta P, Schererz SW, et
al. Mutations in the human Sonic Hedgehog gene cause holoprosen-
cephaly. Nat Genet 1996; 14(3): 357-60. [CrossRef]
9. Towers M, Wolpert L, Tickle C. Gradients of signalling in the develop-
ing limb. Curr Opin Cell Biol 2012; 24(2): 181-7. [CrossRef]
10. Derwińska K, Smyk M, Cooper ML, Bader P, Cheung SW, Stankiewicz
P. PTCH1 duplication in a family with microcephaly and mild develop-
mental delay. Eur J Hum Genet 2009; 17(2): 267-71. [CrossRef]
11. Kaminker CP, Daín L, Lamas MA, Sánchez JM, Opitz JM, Reynolds
JF. Mosaic trisomy 9 syndrome with unusual phenotype. Am J Med
Genet 1985; 22(2): 237-41. [CrossRef]
12. Bruns DA, Campbell E. Twentyfive additional cases of trisomy 9 mo-
saic: Birth information, medical conditions, and developmental status.
Am J Med Genet A 2015; 167A(5): 997-1007. [CrossRef]
56 Mermer et al. Holoprosencephaly with Mosaic Trisomy 9 Syndrome Erciyes Med J 2018; 40(1): 54-6
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Holoprosencephaly (HPE) is the most common congenital cerebral malformation, characterized by impaired forebrain cleavage and midline facial anomalies. Heterozygous mutations in 14 genes have been associated with HPE, and are often inherited from an unaffected parent underlying complex genetic bases. It is now emerging that HPE may result from a combination of multiple genetic events, rather than from a single heterozygous mutation. To explore this hypothesis, we undertook whole exome sequencing (WES) and targeted high-throughput sequencing approaches to identify mutations in HPE subjects. We report here two HPE families in which two mutations are implicated in the disease. In the first family presenting two fetuses with alobar and semi-lobar HPE, we found mutations in two genes involved in HPE, SHH and DISP1, inherited respectively from the father and the mother. The second reported case is a family with a 9-year old girl presenting lobar HPE, harbouring two compound heterozygous mutations in DISP1. Together, these cases of digenic inheritance SHH/DISP1 and autosomal recessive HPE suggest that in some families, several genetic events are necessary to cause HPE. This study highlights the complexity of HPE inheritance and has to be taken into account by clinicians to improve HPE genetic counseling.
Article
Full-text available
Holoprosencephaly (HPE) is the most common structural malformation of the human forebrain. There are several important HPE mutational target genes, including the transcription factor SIX3, which encodes an early regulator of Shh, Wnt, Bmp and Nodal signalling expressed in the developing forebrain and eyes of all vertebrates. To characterise genetic and clinical findings in patients with SIX3 mutations. Patients with HPE and their family members were tested for mutations in HPE-associated genes and the genetic and clinical findings, including those for additional cases found in the literature, were analysed. The results were correlated with a mutation-specific functional assay in zebrafish. In a cohort of patients (n = 800) with HPE, SIX3 mutations were found in 4.7% of probands and additional cases were found through testing of relatives. In total, 138 cases of HPE were identified, 59 of whom had not previously been clinically presented. Mutations in SIX3 result in more severe HPE than in other cases of non-chromosomal, non-syndromic HPE. An over-representation of severe HPE was found in patients whose mutations confer greater loss of function, as measured by the functional zebrafish assay. The gender ratio in this combined set of patients was 1.5:1 (F:M) and maternal inheritance was almost twice as common as paternal. About 14% of SIX3 mutations in probands occur de novo. There is a wide intrafamilial clinical range of features and classical penetrance is estimated to be at least 62%. Our data suggest that SIX3 mutations result in relatively severe HPE and that there is a genotype-phenotype correlation, as shown by functional studies using animal models.
Article
Full-text available
With the exception of the X chromosome, genomic deletions appear to be more prevalent than duplications. Because of a lack of accurate diagnostic methods, submicroscopic duplications have been under-ascertained for a long period. The development of array CGH has enabled the detection of chromosomal microduplications with nearly the same sensitivity as deletions, leading to the discovery of previously unrecognized syndromes. Using a clinical targeted oligonucleotide array (CMA-V6.3 OLIGO), we identified an approximately 360-kb duplication in 9q22.32 in a 21-month-old boy with developmental delay, failure to thrive, and microcephaly. The same duplication was identified in the patient's mother who is also microcephalic and mildly delayed. We have sequenced the chromosomal breakpoints and determined the duplication as tandem in orientation and 363 599 bp in size. The duplicated segment harbors the entire PTCH1 gene. Deletions or loss-of-function mutations of PTCH1 result in basal cell nevus syndrome (Gorlin syndrome), whereas gain-of-function mutations were proposed to lead to holoprosencephaly 7. We propose that patients with microcephaly or holoprosencephaly of unknown origin should also be screened for PTCH1 duplication.
Article
Full-text available
Holoprosencephaly (HPE) is a common developmental defect of the forebrain and frequently the midface in humans, with both genetic and environmental causes. HPE has a prevalence of 1:250 during embryogenesis and 1:16,000 newborn infants, and involves incomplete development and septation of midline structures in the central nervous system (CNS) with a broad spectrum of clinical severity. Alobar HPE, the most severe form which is usually incompatible with postnatal life, involves complete failure of division of the forebrain into right and left hemispheres and is characteristically associated with facial anomalies including cyclopia, a primitive nasal structure (proboscis) and/or midfacial clefting. At the mild end of the spectrum, findings may include microcephaly, mild hypotelorism, single maxillary central incisor and other defects (Fig. 1). This phenotypic variability also occurs between affected members of the same family. The molecular basis underlying HPE is not known, although teratogens, non-random chromosomal anomalies and familial forms with autosomal dominant and recessive inheritance have been described. HPE3 on chromosome 7q36 is one of at least four different loci implicated in HPE. Here, we report the identification of human Sonic Hedgehog (SHH) as HPE3-the first known gene to cause HPE. Analyzing 30 autosomal dominant HPE (ADHPE) families, we found five families that segregate different heterozygous SHH mutations. Two of these mutations predict premature termination of the SHH protein, whereas the others alter highly conserved residues in the vicinity of the alpha-helix-1 motif or signal cleavage site.
Article
Fetal trisomy 9 is a rare chromosomal abnormality, which was difficult to diagnose in the prenatal period. Here is reported a case of mosaic trisomy 9 fetus, prenatally detected by ultrasound examinations in the second trimester and confirmed by karyotyping from amniocentesis and cordocentesis. The fetus presented multiple malformations, especially facial deformity, polycystic kidney disease and genital hypoplasia, which were rare in previous literature.
Article
Limited literature exists on children and adults diagnosed with the mosaic form of trisomy 9. Data from the Tracking Rare Incidence Syndromes (TRIS) project has provided physical characteristics and medical conditions for 14 individuals. This article provides TRIS Survey results of 25 additional cases at two data points (birth and survey completion) as well as developmental status. Results confirmed a number of phenotypic features and medical conditions. In addition, a number of cardiac anomalies were reported along with feeding and respiratory difficulties in the immediate postnatal period. In addition, developmental status data indicated a range in functioning level up to skills in the 36 and 48-month range. Strengths were also noted across the sample in language and communication, fine motor and social-emotional development. Implications for professionals caring for children with this genetic condition are offered. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.
Article
Holoprosencephaly is a brain defect resulting from incomplete cleavage of the embryonic forebrain. It involves forebrain and facial malformations that can range from mild to severe. The epidemiology of holoprosencephaly is largely unknown. Published prevalence estimates have been derived from clinic-based case series, and suggested risk factors for holoprosencephaly have been identified in case reports, without confirmation from systematically conducted population-based studies. Using data from a population-based birth defects registry in California, we describe the epidemiologic and clinical characteristics of cytogenetically and phenotypically distinct types of holoprosencephaly. A total of 121 cases was identified among a cohort of 1,035,386 live births and fetal deaths. The prevalence of holoprosencephaly was 1.2 per 10,000 births (95% confidence interval 1.0–1.4 per 10,000). Of all cases, 41% (50/121) had a chromosomal abnormality, most commonly Trisomy 13. Among the 71 cytogenetically apparently normal cases, 18 had recognizable syndromes and the remaining 53 were of unknown cause. Among the cytogenetically abnormal cases, females had a greater risk than males (odds ratio = 2.3, 95% confidence interval [1.2, 4.4]). Among the cytogenetically normal cases, increased risks were observed among Hispanic whites (OR = 1.8 [0.9, 3.6]) and cases whose mother was born in Mexico (OR = 2.2 [1.0, 4.5]). Approximately 46% of all cases had alobar holoprosencephaly, the most severe form of the forebrain malformation. The facial phenotype did not strongly predict the severity of the brain defect; however, severity was inversely correlated with length of survival. This study is the first to present findings based on such a large population-based series of infants/fetuses affected by holoprosencephaly, and demonstrates the importance of investigating the component subgroups of this rare phenotype. © 1996 Wiley-Liss, Inc.
Article
The developing limb is one of the first systems where it was proposed that a signalling gradient is involved in pattern formation. This gradient for specifying positional information across the antero-posterior axis is based on Sonic hedgehog signalling from the polarizing region. Recent evidence suggests that Sonic hedgehog signalling also specifies positional information across the antero-posterior axis by a timing mechanism acting in parallel with graded signalling. The progress zone model for specifying proximo-distal pattern, involving timing to provide cells with positional information, continues to be challenged, and there is further evidence that graded signalling by retinoic acid specifies the proximal part of the limb. Other recent papers present the first evidence that gradients of signalling by Wnt5a and FGFs govern cell behaviour involved in outgrowth and morphogenesis of the developing limb.
Article
We report on a newborn infant with mosaic trisomy 9. The patient shared only a few anomalies with the previously reported cases of this chromosome abnormality but had a severe craniofacial malformation not yet reported in this syndrome.